Literature DB >> 10079104

Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination.

L Gangi-Peterson1, D H Sorscher, J W Reynolds, T B Kepler, B S Mitchell.   

Abstract

Template-independent nucleotide additions (N regions) generated at sites of V(D)J recombination by terminal deoxynucleotidyl transferase (TdT) increase the diversity of antigen receptors. Two inborn errors of purine metabolism, deficiencies of adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP), result in defective lymphoid development and aberrant pools of 2'-deoxynucleotides that are substrates for TdT in lymphoid precursors. We have asked whether selective increases in dATP or dGTP pools result in altered N regions in an extrachromosomal substrate transfected into T-cell or pre-B-cell lines. Exposure of the transfected cells to 2'-deoxyadenosine and an ADA inhibitor increased the dATP pool and resulted in a marked increase in A-T insertions at recombination junctions, with an overall decreased frequency of V(D)J recombination. Sequence analysis of VH-DH-JH junctions from the IgM locus in B-cell lines from ADA-deficient patients demonstrated an increase in A-T insertions equivalent to that found in the transfected cells. In contrast, elevation of dGTP pools, as would occur in PNP deficiency, did not alter the already rich G-C content of N regions. We conclude that the frequency of V(D)J recombination and the composition of N-insertions are influenced by increases in dATP levels, potentially leading to alterations in antigen receptors and aberrant lymphoid development. Alterations in N-region insertions may contribute to the B-cell dysfunction associated with ADA deficiency.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079104      PMCID: PMC408138          DOI: 10.1172/JCI4320

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Interdependence of N nucleotide addition and recombination site choice in V(D)J rearrangement.

Authors:  T B Kepler; M Borrero; B Rugerio; S K McCray; S H Clarke
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

2.  High-throughput purification of M13 templates for DNA sequencing.

Authors:  R K Wilson
Journal:  Biotechniques       Date:  1993-09       Impact factor: 1.993

3.  Unequal signal and coding joint formation in human V(D)J recombination.

Authors:  G H Gauss; M R Lieber
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Biochemical properties of purified human terminal deoxynucleotidyltransferase.

Authors:  M R Deibel; M S Coleman
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

5.  Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.

Authors:  J M Wilson; B S Mitchell; P E Daddona; W N Kelley
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

6.  Mutational analysis of residues in the nucleotide binding domain of human terminal deoxynucleotidyl transferase.

Authors:  B Yang; K N Gathy; M S Coleman
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

7.  Mice lacking TdT: mature animals with an immature lymphocyte repertoire.

Authors:  S Gilfillan; A Dierich; M Lemeur; C Benoist; D Mathis
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

8.  Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes.

Authors:  T Komori; A Okada; V Stewart; F W Alt
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

9.  Isolation and characterization of the Xenopus terminal deoxynucleotidyl transferase.

Authors:  A Lee; E Hsu
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

10.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Authors:  A Cohen; R Hirschhorn; S D Horowitz; A Rubinstein; S H Polmar; R Hong; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

View more
  18 in total

1.  Nucleotide Composition of Human Ig Nontemplated Regions Depends on Trimming of the Flanking Gene Segments, and Terminal Deoxynucleotidyl Transferase Favors Adding Cytosine, Not Guanosine, in Most VDJ Rearrangements.

Authors:  Tina Funck; Mike Bogetofte Barnkob; Nanna Holm; Line Ohm-Laursen; Camilla Slot Mehlum; Sören Möller; Torben Barington
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

2.  Association of terminal deoxynucleotidyl transferase with Ku.

Authors:  K N Mahajan; L Gangi-Peterson; D H Sorscher; J Wang; K N Gathy; N P Mahajan; W H Reeves; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 3.  Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation.

Authors:  Kelli W Williams; Joshua D Milner; Alexandra F Freeman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

Review 4.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

Review 5.  How I treat ADA deficiency.

Authors:  H Bobby Gaspar; Alessandro Aiuti; Fulvio Porta; Fabio Candotti; Michael S Hershfield; Luigi D Notarangelo
Journal:  Blood       Date:  2009-07-28       Impact factor: 22.113

Review 6.  hPso4/hPrp19: a critical component of DNA repair and DNA damage checkpoint complexes.

Authors:  K Mahajan
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

7.  SAMHD1-mediated dNTP degradation is required for efficient DNA repair during antibody class switch recombination.

Authors:  Afzal Husain; Jianliang Xu; Hodaka Fujii; Mikiyo Nakata; Maki Kobayashi; Ji-Yang Wang; Jan Rehwinkel; Tasuku Honjo; Nasim A Begum
Journal:  EMBO J       Date:  2020-06-08       Impact factor: 11.598

Review 8.  Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.

Authors:  Donald B Kohn; Michael S Hershfield; Jennifer M Puck; Alessandro Aiuti; Annaliesse Blincoe; H Bobby Gaspar; Luigi D Notarangelo; Eyal Grunebaum
Journal:  J Allergy Clin Immunol       Date:  2018-09-05       Impact factor: 10.793

9.  B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients.

Authors:  Immacolata Brigida; Aisha V Sauer; Francesca Ferrua; Stefania Giannelli; Samantha Scaramuzza; Valentina Pistoia; Maria Carmina Castiello; Barbara H Barendregt; Maria Pia Cicalese; Miriam Casiraghi; Chiara Brombin; Jennifer Puck; Klaus Müller; Lucia Dora Notarangelo; Davide Montin; Joris M van Montfrans; Maria Grazia Roncarolo; Elisabetta Traggiai; Jacques J M van Dongen; Mirjam van der Burg; Alessandro Aiuti
Journal:  J Allergy Clin Immunol       Date:  2014-02-05       Impact factor: 10.793

10.  Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID).

Authors:  Claire Booth; H Bobby Gaspar
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.